Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 319 
This article has been cited by
1Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-aBased Therapy
Bassem Refaat,Ahmed Mohamed Ashshi,Adel Galal El-Shemi,Esam Azhar
Mediators of Inflammation.2015;2015()1
[DOI]
2NS5A Sequence Heterogeneity and Mechanisms of Daclatasvir Resistance in Hepatitis C Virus Genotype 4 Infection
Nannan Zhou,Dennis Hernandez,Joseph Ueland,Xiaoyan Yang,Fei Yu,Karen Sims,Philip D. Yin,Fiona McPhee
Journal of Infectious Diseases.2016;213(2)206
[DOI]
3Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China
ZhiLi Niu,PingAn Zhang,YongQing Tong
SpringerPlus.2016;5(1)206
[DOI]
4Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial
Tarik Asselah,Christophe Hézode,Roula B Qaqish,Magdy ElKhashab,Tarek Hassanein,George Papatheodoridis,Jordan J Feld,Christophe Moreno,Stefan Zeuzem,Peter Ferenci,Yao Yu,Rebecca Redman,Tami Pilot-Matias,Niloufar Mobashery
The Lancet Gastroenterology & Hepatology.2016;1(1)25
[DOI]
5Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4)
Christophe Hézode,Laurent Alric,Ashley Brown,Tarek Hassanein,Mario Rizzetto,Maria Buti,Marc Bourlière,Dominique Thabut,Esther Molina,Vinod Rustgi,Didier Samuel,Fiona McPhee,Zhaohui Liu,Philip D Yin,Eric Hughes,Michelle Treitel
Antiviral Therapy.2016;21(3)195
[DOI]
6Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-a, viral load and liver damage
Bassem Refaat,Ahmed Mohammed Ashshi,Adel Galal El-Shemi,Adnan AlZanbagi
Clinical and Experimental Medicine.2015;15(3)293
[DOI]
7Efficacy and Safety of Simeprevir or Daclatasvir in Combination With Sofosbuvir for the Treatment of Hepatitis C Genotype 4 Infection
Mohammed A. Babatin,Abdullah S. Alghamdi,Ali Albenmousa,Abdulla Alaseeri,Mahdi Aljarodi,Haziz Albiladi,Ashwaq Alsahafi,Mohammed Almugharbal,Hammad S. Alothmani,Faisal M. Sanai,Khalid I. Bzeizi
Journal of Clinical Gastroenterology.2018;52(5)452
[DOI]
8Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4
Christophe Moreno,Christophe Hezode,Patrick Marcellin,Stefan Bourgeois,Sven Francque,Didier Samuel,Fabien Zoulim,Jean-Didier Grange,Umesh Shukla,Oliver Lenz,Sivi Ouwerkerk-Mahadevan,Bart Fevery,Monika Peeters,Maria Beumont,Wolfgang Jessner
Journal of Hepatology.2015;62(5)1047
[DOI]
9Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia
Shiaw-Hooi Ho,Kee-Peng Ng,Harvinder Kaur,Khean-Lee Goh
Hepatobiliary & Pancreatic Diseases International.2015;14(3)281
[DOI]
10Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients
Ashraf Tabll,Reem El Shenawy,Hazem Elsharkawy,Faten Zahran Mohamed
Human Antibodies.2019;27(4)265
[DOI]
11Meta-analysis
Brittany E. Yee,Nghia H. Nguyen,Bing Zhang,Philip Vutien,Carrie R. Wong,Glen A. Lutchman,Mindie H. Nguyen
European Journal of Gastroenterology & Hepatology.2014;26(11)1189
[DOI]
12New insight into HCV E1/E2 region of genotype 4a
Nehal Hussein,Abdel-Rahman N Zekri,Mohamed Abouelhoda,Hanaa M Alam El-din,Ahmed Abdelwahab Ghamry,Mahmoud A Amer,Ghada M sherif,Abeer A Bahnassy
Virology Journal.2014;11(1)1189
[DOI]
13Genetic diversity of hepatitis C virus in Ethiopia
Gadissa Bedada Hundie,V. Stalin Raj,Daniel GebreMichael,Suzan D. Pas,Bart L. Haagmans,Jason Blackard
PLOS ONE.2017;12(6)e0179064
[DOI]
14Tracing the epidemic history of hepatitis C virus genotypes in Saudi Arabia
Anis Khan,Mohammed Al Balwi,Latifah AlAyyar,Ibrahim AlAbdulkareem,Abdulkareem Albekairy,Abdulrahman Aljumah
Infection, Genetics and Evolution.2017;52(6)82
[DOI]
15Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia
Medhat K. Shier,James C. Iles,Mohammad S. El-Wetidy,Hebatallah H. Ali,Mohammad M. Al Qattan,Dimitrios Paraskevis
PLOS ONE.2017;12(9)e0184163
[DOI]
16Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)
Tarik Asselah,Negar Niki Alami,Christophe Moreno,Stanislas Pol,Stylianos Karatapanis,Michael Gschwantler,Yves Horsmans,Ioannis Elefsiniotis,Dominique Larrey,Carlo Ferrari,Mario Rizzetto,Alessandra Orlandini,Jose Luis Calleja,Savino Bruno,Gretja Schnell,Roula Qaqish,Rebecca Redman,Tami Pilot-Matias,Sarah Kopecky-Bromberg,Yao Yu,Niloufar Mobashery
Health Science Reports.2019;2(3)e92
[DOI]
17Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis
Brittany E Yee,Nghia H Nguyen,Bing Zhang,Derek Lin,Philip Vutien,Carrie R Wong,Glen A Lutchman,Mindie H Nguyen
BMJ Open Gastroenterology.2015;2(1)e000049
[DOI]
18Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium
Delphine Degré,Thomas Sersté,Luc Lasser,Jean Delwaide,Peter Starkel,Wim Laleman,Philippe Langlet,Hendrik Reynaert,Stefan Bourgeois,Thomas Vanwolleghem,Sergio Negrin Dastis,Thierry Gustot,Anja Geerts,Christophe Van Steenkiste,Chantal de Galocsy,Antonia Lepida,Hans Orlent,Christophe Moreno,Ravi Jhaveri
PLOS ONE.2017;12(1)e0170933
[DOI]
19Determinants of Infection Outcome in HCV-Genotype 4
Rania A. Zayed,Dalia Omran,Abeer A. Zayed,Lobna O. Elmessery
Viral Immunology.2017;30(8)560
[DOI]
20The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia
Ahmed A. Al-Qahtani,Guy Baele,Nisreen Khalaf?,Marc A. Suchard,Mashael R. Al-Anazi,Ayman A. Abdo,Faisal M. Sanai,Hamad I. Al-Ashgar,Mohammed Q. Khan,Mohammed N. Al-Ahdal,Philippe Lemey,Bram Vrancken
Scientific Reports.2017;7(1)560
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts

Join us